Free Trial
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.44 -0.05 (-3.36%)
Closing price 04:00 PM Eastern
Extended Trading
$1.46 +0.02 (+1.04%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Key Stats

Today's Range
$1.40
$1.50
50-Day Range
$1.15
$1.76
52-Week Range
$1.00
$3.00
Volume
82,299 shs
Average Volume
550,384 shs
Market Capitalization
$9.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

INBS MarketRank™: 

Intelligent Bio Solutions scored higher than 5% of companies evaluated by MarketBeat, and ranked 921st out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Intelligent Bio Solutions.

  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.25) to $0.35 per share.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 1.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.82% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently decreased by 0.32%, indicating that investor sentiment is improving.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.82% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently decreased by 0.32%, indicating that investor sentiment is improving.
  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for INBS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.54% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    Only 32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Stock News Headlines

Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $1.40 at the start of the year. Since then, INBS stock has increased by 2.1% and is now trading at $1.43.
View the best growth stocks for 2025 here
.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced its quarterly earnings data on Thursday, February, 13th. The company reported ($0.50) EPS for the quarter. The company earned $610 billion during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 146.03% and a negative net margin of 323.79%.

Shares of Intelligent Bio Solutions reverse split on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Intelligent Bio Solutions' top institutional investors include Alyeska Investment Group L.P. (8.88%) and Altium Capital Management LLC (2.19%).
View institutional ownership trends
.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

Company Calendar

Last Earnings
2/13/2025
Today
5/30/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INBS
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.16 million
Net Margins
-323.79%
Pretax Margin
-324.91%

Debt

Sales & Book Value

Annual Sales
$2.94 million
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
1.86

Miscellaneous

Free Float
5,264,000
Market Cap
$10.30 million
Optionable
Not Optionable
Beta
4.63
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners